| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C0003062> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C0014432> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C0028131> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C1257961> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C2713498> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C2936405> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C3661486> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34111397_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Department of Pharmacology, PGIMER, Chandigarh, India.\', \'Department of Ophthalmology, GMCH-32, Chandigarh, India.\', \'Department of Biophysics, PGIMER, Chandigarh, India.\', \'Department of Pharmacology, PGIMER, Chandigarh, India. Electronic address: drbikashus@yahoo.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Avti_Pramod> <https://research.tib.eu/covid-19/entity/Bhattacharyya_Anusuya> <https://research.tib.eu/covid-19/entity/Chhimpa_Neeraj> <https://research.tib.eu/covid-19/entity/Kaur_Hardeep> <https://research.tib.eu/covid-19/entity/Kumar_Subodh> <https://research.tib.eu/covid-19/entity/Medhi_Bikash> <https://research.tib.eu/covid-19/entity/Prajapat_Manisha> <https://research.tib.eu/covid-19/entity/Prakash_Ajay> <https://research.tib.eu/covid-19/entity/Sarma_Phulen> <https://research.tib.eu/covid-19/entity/Sharma_Saurabh> <https://research.tib.eu/covid-19/entity/Singh_Ashutosh> <https://research.tib.eu/covid-19/entity/Singh_Rahul> <https://research.tib.eu/covid-19/entity/Thota_Prasad>
?:doi	S0014-2999(21)00386-110.1016/j.ejphar.2021.174233
?:doi	<https://research.tib.eu/covid-19/entity/S0014-2999%2821%2900386-110.1016/j.ejphar.2021.174233>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Review>
?:journal	European journal of pharmacology
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34111397>
?:pmid	<https://research.tib.eu/covid-19/entity/34111397>
?:pmid	34111397
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	1.057
?:rankingScore_hIndex	161
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0058099_INTERACTS_WITH_C0178785> <https://research.tib.eu/covid-19/entity/C0063041_AFFECTS_C0879626> <https://research.tib.eu/covid-19/entity/C0063041_INTERACTS_WITH_C1422064>
?:title	Efficacy and safety of dihydroorotate dehydrogenase (DHODH) inhibitors \'leflunomide\' and \'teriflunomide\' in Covid-19: A narrative review.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34111397>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34111397>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all